CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation
Hannah Lawson(University of London), Kamil R. Kranc(Queen Mary University of London), Kirsteen J. Campbell(Cancer Research UK), Catarina Sepúlveda(MRC Centre for Regenerative Medicine), Neil P. Rodrigues(Cardiff University), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Andrea Tavosanis(Springer Nature (Germany)), Elise Georges(Roslin Institute), Jozef Durko(Queen Mary University of London), Suzanne Cory(The University of Melbourne), Aarushi Bellani(Institute of Cancer Research), Joana Campos(Queen Mary University of London), Dónal O’Carroll(MRC Centre for Regenerative Medicine), Catarina Martins‐Costa(Institute of Molecular Biotechnology), Amélie V. Guitart(MRC Centre for Regenerative Medicine), Lewis Allen(MRC Centre for Regenerative Medicine), Melania Barile(Wellcome/MRC Cambridge Stem Cell Institute), Christopher Mapperley(MRC Centre for Regenerative Medicine), Louie N. van de Lagemaat(Queen Mary University of London), Arnaud Villacreces(MRC Centre for Regenerative Medicine)
Cited by 19
Related Papers
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
|Cell stem cell|2019|552
Targeting BCL-2 regulated apoptosis in cancer
|Open Biology|2018|538
Bim is a suppressor of Myc-induced mouse B cell leukemia
|Proceedings of the National Academy of Sciences|2004|482